-
5 days ago | 
stockhead.com.au | Rob Badman
It’s no easy gig analysing share prices and company performance – especially amid current macroeconomic conditions. Somebody’s got to do it, though. And so, every week two experts from The Australian’s share tips columnist pool give us their buy, hold and sell recommendations. Mark Goulopoulos, Cumulus WealthWoodside Energy Group (ASX:WDS)A global oil and gas producer with world class assets, a solid growth outlook and an attractive dividend yield.
-
1 week ago | 
stockhead.com.au | Rob Badman |Phoebe Shields
Everything you need to know before the ASX opens. Pic: Getty Images Good morning, and welcome to Rise and Shine on Tuesday, May 6, 2025. We won’t tarry here long this morn, but before we get stuck into the info you’ve likely come here for (further below), there’s time for a very quick nod to May 6, 88 years ago.
-
2 weeks ago | 
stockhead.com.au | Rob Badman |Phoebe Shields
George Washington, rolling in his grave on a daily basis. Pic via Getty Images Good morning, and welcome to Rise and Shine, Wednesday April 30.
-
2 weeks ago | 
stockhead.com.au | Rob Badman |Phoebe Shields
Will markets shine today like Joan of Arc or burn out? (Also like Joan.) We'll know soon enough. Pic via Getty Images Good morning, and welcome to Rise and Shine, Tuesday April 29.
-
2 weeks ago | 
stockhead.com.au | Rob Badman |Eddy Sunarto
News 23 minutes ago Good morning, and welcome to Rise and Shine.
-
1 month ago | 
stockhead.com.au | Rob Badman |Phoebe Shields
Stockhead is providing factual information where there is a reasonable likelihood of doubt. The information is not intended to imply any recommendation or opinion about a financial product. A NOTE ABOUT RELEVANT ADVERTISING We collect information about the content (including ads) you use across this site and use it to make both advertising and content more relevant to you on our network and other sites.
-
1 month ago | 
stockhead.com.au | Rob Badman
Stockhead’s monthly crypto wrap, Mooners and Shakers, is brought to you by We’re not going to sugarcoat it, the crypto market is in the gutter right now. Thanks, DonaldThen again… it’s hardly the lone ranger among Trump-roiled markets and sectors, is itIn fact, let’s sugar it after all… there are some silver linings to be found.
-
1 month ago | 
stockhead.com.au | Rob Badman
Stockhead has been undergoing a bit of a transformation of late. And you can see a good deal of that manifested in the brand, spanking new website you’re currently viewing. Along with “clean, modern lines”, a faster, improved navigational experience and a much stronger focus on video and features content, we’ve reconstructed the site keeping Stockhead’s DNA very much intact. Consider it an upgrade if not a total revamp.
-
1 month ago | 
stockhead.com.au | Rob Badman
Nanosonics (ASX:NAN) chief Michael Kavanagh says he’s “very proud” of the device maker’s ability to win US Food and Drug Administration (FDA) approval for its second medical probe sterilisation device, Coris. He’s chuffed just not just by the assent, but because the device was approved under the more difficult de novo (new device) pathway. Overwhelmingly, the FDA has approved devices under the 510(k) existing (predicate) device route.
-
1 month ago | 
stockhead.com.au | Rob Badman
In the arvo session, the ASX held on to early gains… by a threadNervy investor/trader eyes now await updates from the US on yet more inflation data and tariff announcementsAmid the turmoil, wouldn’t you know it, gold stole the show After chugging along without too much drama this morning, the ASX was the Little Bourse that Could this arvo, getting over a hump and eventually carrying its stocks to a +0.16 win. Not as good as it was potentially looking at lunch but a better result than yesterday.
